Misplaced Pages

Dihydrouracil: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 18:39, 28 February 2011 editYikrazuul (talk | contribs)Rollbackers1,991 editsm svg← Previous edit Latest revision as of 20:54, 14 May 2024 edit undoSpiderpig662 (talk | contribs)Extended confirmed users12,855 editsm Removed duplicate tagTag: Manual revert 
(18 intermediate revisions by 17 users not shown)
Line 1: Line 1:
{{chembox {{chembox
| Verifiedfields = changed
| verifiedrevid = 384093002
| Watchedfields = changed
|ImageFile=Dihydrouracil.svg
| verifiedrevid = 416414074
|ImageSize=120px
| ImageFile=Dihydrouracil.svg
|IUPACName=hexahydropyrimidine-2,4-dione
| ImageSize=120px
|OtherNames=
| PIN = 1,3-Diazinane-2,4-dione
| OtherNames= Dihydropyrimidine-2,4(1''H'',3''H'')-dione
|Section1={{Chembox Identifiers |Section1={{Chembox Identifiers
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=504-07-4 | CASNo=504-07-4
| PubChem=649
| UNII_Ref = {{fdacite|correct|FDA}}
| SMILES=C1CNC(=O)NC1=O
| UNII = 016FR52RU5
| MeSHName=Dihydrouracil
| PubChem=649
| SMILES=C1CNC(=O)NC1=O
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 629
| InChI = 1/C4H6N2O2/c7-3-1-2-5-4(8)6-3/h1-2H2,(H2,5,6,7,8)
| InChIKey = OIVLITBTBDPEFK-UHFFFAOYAM
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C4H6N2O2/c7-3-1-2-5-4(8)6-3/h1-2H2,(H2,5,6,7,8)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = OIVLITBTBDPEFK-UHFFFAOYSA-N
| MeSHName=Dihydrouracil
}} }}
|Section2={{Chembox Properties |Section2={{Chembox Properties
| Formula=C<sub>4</sub>H<sub>6</sub>N<sub>2</sub>O<sub>2</sub> | Formula=C<sub>4</sub>H<sub>6</sub>N<sub>2</sub>O<sub>2</sub>
| MolarMass=114.10264 | MolarMass=114.10264
| Appearance= | Appearance=
| Density= | Density=
| MeltingPt= | MeltingPt=
| BoilingPt= | BoilingPt=
| Solubility= | Solubility=
}} }}
|Section3={{Chembox Hazards |Section3={{Chembox Hazards
| MainHazards= | MainHazards=
| FlashPt= | FlashPt=
| AutoignitionPt =
| Autoignition=
}} }}
}} }}


'''Dihydrouracil''' is an intermediate in the catabolism of ].<ref>{{cite journal |last1=Nakamura |first1=A |last2=Kikuchi |first2=K |last3=Ohishi |first3=T |last4=Masuike |first4=T |title=. |journal=Gan to Kagaku Ryoho. Cancer & Chemotherapy |date=March 2004 |volume=31 |issue=3 |pages=381–6 |pmid=15045945}}</ref> It is the base present in the ] ].
'''Dihydrouracil''' is an intermediate in the catabolism of ].


==See also== ==See also==
Line 33: Line 46:
* ] * ]
* ] * ]
==References==

{{reflist}}
{{Nucleotide metabolism intermediates}} {{Nucleotide metabolism intermediates}}{{Nucleobases, nucleosides, and nucleotides}}

]
] ]
] ]
Line 41: Line 55:


{{organic-compound-stub}} {{organic-compound-stub}}

]
Dihydrouracil: Difference between revisions Add topic